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METHODS: M-NCAS data were collected from nursing
staff ratings of nursing home patients diagnosed with
dementia (N = 281), in a randomized double-blind 
clinical trial comparing risperidone to placebo (RIS-AUS-
5 trial). For each item nurses rated the extent to which
they agree the target patient exhibits the behavior (agree,
partially agree, doubtful/unsure, don’t agree) and the
extent to which the behavior is difﬁcult to cope with (very
easy, easy, difﬁcult, very difﬁcult). Exploratory factor
analyses were performed separately for “agree” and
“cope” scales to determine if empirically and conceptu-
ally valid subscales exist. Internal consistency reliability
was assessed via Cronbach’s alpha. Correlations with the
BEHAVE-AD and Cohen-Mansﬁeld Agitation Inventory
were examined to evaluate construct validity.
RESULTS: Factor analysis resulted in identiﬁcation of 3
agree subscales (difﬁculty, attention seeking, autonomy)
and 5 cope subscales (predictability, self direction, need-
iness, job satisfaction, affect). Total scores were internally
consistent, with alphas of 0.74 for the agree scale and
0.95 for the cope scale. Internal consistency reliability
was also acceptable for the 3 agree subscales (0.69, 0.77,
0.57) and for the 5 cope subscales (0.89, 0.86, 0.83, 0.86,
0.79). The M-NCAS agree and cope total scale scores cor-
related most highly with the BEHAVE-AD aggressiveness
and anxiety/phobia subscales (r = 0.36, r = 0.35; r = 0.43,
r = 0.35 respectively: p < 0.001) and the CMAI
verbal/non-aggression and aggression subscales (r = 0.45,
r = 0.32; r = 0.34, r = 0.31, p < 0.001), indicating 
adequate construct validity.
CONCLUSIONS: The 32-item M-NCAS is an internally
consistent and valid scale for capturing both dementia-
speciﬁc behaviors and nursing perception of job burden
associated with those behaviors. The M-NCAS provides
detailed item-level as well as subscale-level data.
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About 1 in every 20 employees experience depression in
the U.S. A recent study estimated that in 1990 the eco-
nomic costs of depression amounted to $43 billion, with
absenteeism alone contributing $12 billion.
OBJECTIVES: The study used 1996–1997 data col-
lected in crime-ridden and low-income neighborhoods of
Miami, Florida to 1) examine the relationship between
depression and employment; 2) conditional on being
employed, estimate the effect of depression on annual
weeks worked; 3) examine the robustness of the model
estimates to the co-morbid effects of drug use.
METHODS: The labor supply measures included
employment in past 30 days and number of weeks
worked in past 12 months. The analysis estimated a 
univariate probit model of employment as well as a
bivariate probit model of depression and employment,
which accounted for the possible correlation between the
unobserved determinants of depression and employment.
The annual weeks worked speciﬁcation was estimated by
a standard Tobit and an instrumental variable Tobit
model, which, besides the censoring of the observations,
accounted for the possible endogeneity of depression.
RESULTS: Results indicate that depressed individuals
had a 0.18 lower probability of employment relative to
non-depressed individuals in the univiariate probit model
and a 0.15 lower probability in the bivariate model. Both
standard and IV Tobit models found that depression 
signiﬁcantly reduced the number of annual weeks worked
by 8 weeks. Co-morbid drug use signiﬁcantly contributed
to the estimated effects of depression.
CONCLUSIONS: Prevention and/or treatment of mental
health problems such as depression may yield economic
beneﬁts by promoting employment and enhancing labor
supply. While expansion of mental health services may be
particularly beneﬁcial to the unemployed, employers may
ﬁnd it economically efﬁcient to allocate more resources
to stress management training and job redesign.
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OBJECTIVE: This study was designed 1) to investigate
the impact of primary payer type on access to antide-
pressant pharmacotherapy among patients diagnosed
with depression; 2) to identify predictors of antidepres-
sant pharmacotherapy, prescription for an SSRI or an
SNRI, and psychotherapy among patients diagnosed with
depression.
METHOD: Data from 1999 National Ambulatory
Medical Care Survey (NAMCS) was used for this analy-
sis. Odd ratios (OR) and 95% conﬁdence intervals (CI)
were used to investigate the impact of primary payer 
type on access to antidepressant pharmacotherapy and 
to elucidate the factors predictive of receipt of anti-
depressants, an SSRI or an SNRI and psychotherapy.
Model variables included age, gender, race, payer type,
region, metropolitan status, self-report depression as a
reason for the ofﬁce-based encounter, and duration of the
encounter.
RESULTS: Among estimated 19,445,888 patients 
diagnosed with depression in 1999, 74.0% were pre-
scribed with antidepressant pharmacotherapy, 56.7%
were prescribed an SSRI or SNRI and 40.8% received
psychotherapy. Medicaid beneﬁciaries (7.8%) were 70% 
